Search
Sign In
Sign In
Sources
7 Total Sources
Novo Nordisk Regains Obesity Momentum as Oral Wegovy Leads Lilly's Foundayo in $100 Billion Market
Left
50%
Center
25%
Right
25%
All
7
Left
2
Center
1
Right
1
Others
3
Global Banking And Finance Review
42d ago
Novo Nordisk Regains Obesity Drug Market Momentum with Wegovy Against Eli Lilly
Reuters
42d ago
Obesity battle heats up again as Novo claws way back into race with Lilly | Reuters
TheStreet
42d ago
Novo Nordisk stock falls after heart drug trial fails - TheStreet
Yahoo News Malaysia
42d ago
Novo Nordisk shares in hot water after disappointing trial - Yahoo News Malaysia
AD HOC NEWS
42d ago
Novo Nordisk's Pre-Market Slide Sets Up a High-Stakes Reckoning
CNBC
42d ago
Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
matterfact.com
42d ago
Novo Nordisk Trial Failure Reopens the Obesity Debate as Medicare Starts Paying for GLP-1s - Weekly Pharma / Biotech / Life Sciences Podcast Recap - Week of August 2, 2026 | Matterfact Podcast Newsletter